Skip to main content
hello world

Cipher Pharmaceuticals: Stocks Overvalued by Analyst Consensus on TSX (CPH)

AI-generated - The Globe and Mail - Sat Apr 27, 8:52AM CDT

Cipher Pharmaceuticals Inc is among the group of overvalued stocks on the Toronto Stock Exchange. This means the consensus value for each stock on this list is below its current price.

This report is generated monthly. It provides the close price and target price for these companies along with the number of analysts covering the stock. Also included is the fiscal year for the target price as sometimes these analyst targets are not for the current or even the next fiscal year. Stocks in this category are generally sold to preserve capital.

There may be a number of reasons why a company would be on this list. Companies with a large analyst following with a difference in price versus target are worth exploring in more detail.

SymbolNameTarget YearClose PriceTarget Price MeanCurrencyTarget Price # Estimates
NANational Bank of Canada2024112.06111.6667CAD9
TECK-ATeck Resources Ltd202467.667.5CAD7
TECK-BTeck Resources Ltd202467.6567.5CAD7
CTCCanadian Tire Corp Ltd2024253.33153CAD8
ERFEnerplus Corp202427.9127.3289CAD6
TCNTricon Residential Inc202415.3314.693CAD7
SILSilverCrest Metals Inc202411.5710.4643CAD7
SIISprott Inc202454.754.5CAD2
WEEDCanopy Growth Corp202511.865.1667CAD3
ACBAurora Cannabis Inc20259.168.5CAD4
MRT-UNMorguard Real Estate Investment Trust20245.335.25CAD2
D-UNDream Office Real Estate Investment Trust202419.1917.875CAD8
AIDXHealwell AI Inc20241.551.2833CAD3
CPHCipher Pharmaceuticals Inc20248.58.025CAD2
FCD-UNFirm Capital Property Trust202454.75CAD1
TNT-UNTrue North Commercial REIT20249.589.1875CAD4
TRZTransat AT Inc20243.473.4125CAD4
ANRGAnaergia Inc20240.2950.25CAD1
LSPKLifeSpeak Inc20240.630.575CAD4
INO-UNInovalis Real Estate Investment Trust20241.121CAD1
PMTPerpetual Energy Inc20240.530.5CAD2

All data provided as of April 25, 2024.

More about Cipher Pharmaceuticals Inc

Cipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, specialty medicines, and Out-Licensed Products among others. The company's geographical operational areas include Canada and the United States.

Cipher Pharmaceuticals Inc is listed under CPH on the Toronto Stock Exchange.

Artificial intelligence at Report on Business

Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.